Englisch

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Beschreibung

Adult | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
Beschreibung

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4288755
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2,1]
C4288304
UMLS CUI [2,2]
C0205179
UMLS CUI [2,3]
C1517927
>=1 measurable tumor lesion;
Beschreibung

Measurable lesion Quantity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
ecog performance status 0-1.
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy or treatment with another systemic anti-cancer agent;
Beschreibung

Prior Chemotherapy | Antineoplastic Agents Systemic

Datentyp

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2,1]
C0003392
UMLS CUI [2,2]
C0205373
evidence of cns metastases;
Beschreibung

CNS metastases

Datentyp

boolean

Alias
UMLS CUI [1]
C0686377
history of grade 2 or higher hemoptysis;
Beschreibung

Hemoptysis CTCAE Grades

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019079
UMLS CUI [1,2]
C1516728
evidence of tumor invading or abutting major blood vessels;
Beschreibung

Tumor Invasion Blood Vessel Major

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1269955
UMLS CUI [1,2]
C0005847
UMLS CUI [1,3]
C0205164
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
Beschreibung

Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007131
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0007117
UMLS CUI [4,3]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0553723
UMLS CUI [5,3]
C1522326
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0600139
UMLS CUI [6,3]
C0392752
UMLS CUI [7,1]
C1705847
UMLS CUI [7,2]
C0007124
clinically significant cardiovascular disease;
Beschreibung

Cardiovascular Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
Beschreibung

Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0003280
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0443225
UMLS CUI [3]
C0016018
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Non-Small Cell Lung Cancer NCT00700180

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally
Item
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer (nsclc);
boolean
C4288755 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C4288304 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
Measurable lesion Quantity
Item
>=1 measurable tumor lesion;
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | Antineoplastic Agents Systemic
Item
prior chemotherapy or treatment with another systemic anti-cancer agent;
boolean
C1514457 (UMLS CUI [1])
C0003392 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
CNS metastases
Item
evidence of cns metastases;
boolean
C0686377 (UMLS CUI [1])
Hemoptysis CTCAE Grades
Item
history of grade 2 or higher hemoptysis;
boolean
C0019079 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Tumor Invasion Blood Vessel Major
Item
evidence of tumor invading or abutting major blood vessels;
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
Malignant Neoplasms | Exception Non-Small Cell Lung Carcinoma | Exception Carcinoma in situ of uterine cervix Treated | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Prostate carcinoma Localized | Exception DCIS
Item
malignancies other than nsclc within 5 years prior to randomization, other than adequately treated cancer in situ of cervix, basal or squamous cell skin cancer, localized prostate cancer or dcis;
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0007117 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C1705847 (UMLS CUI [5,1])
C0553723 (UMLS CUI [5,2])
C1522326 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C0600139 (UMLS CUI [6,2])
C0392752 (UMLS CUI [6,3])
C1705847 (UMLS CUI [7,1])
C0007124 (UMLS CUI [7,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease;
boolean
C0007222 (UMLS CUI [1])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent use of aspirin (>325mg/day) or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
Zum Seitenanfang zurückkehren